The Role of Lymphatic Transport in Enhancing Oral Protein and Peptide Drug Delivery

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Drug Development and Industrial Pharmacy

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1081/DDC-120014573PMID 12455465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assembly and secretion of lipoproteins

  2002cited by this paper
• Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.

  2000influential reference
• Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

  2000influential reference
• Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.

  1999cited by this paper
• Intestinal absorption and biliary secretion of cholesterol in rats with nephrotic syndrome.

  1998cited by this paper
• Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.

  1998influential reference
• Chronic Collection of Mesenteric Lymph From Conscious, Tethered Rats.

  1998influential reference
• Uptake of drugs into the intestinal lymphatics after oral administration

  1997influential reference
• The potential of oily formulations for drug delivery to the gastro-intestinal tract

  1997influential reference
• [Delivery system design for improvement of intestinal absorption of peptide drugs].

  1997influential reference
• Binding of drugs to monoglyceride-based drug delivery systems

  1997cited by this paper
• A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.

  1996cited by this paper
• Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

  1996cited by this paper
• Chapter 17 - Structure, assembly and secretion of lipoproteins

  1996influential reference
• Lipophilic prodrugs designed for intestinal lymphatic transport

  1996influential reference
• Estimation of oral drug absorption in man based on intestine permeability in rats.

  1996cited by this paper
• Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats.

  1996cited by this paper
• The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats.

  1996cited by this paper
• Comparison Between Permeability Coefficients in Rat and Human Jejunum

  1996cited by this paper
• Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane

  1995cited by this paper
• Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals

  1995cited by this paper
• Review of cholesterol absorption with emphasis on dietary and biliary cholesterol.

  1994cited by this paper
• Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach

  1994cited by this paper
• Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs

  1994cited by this paper
• Enhancement of the intestinal absorption of a cyclosporine derivative by milk fat globule membrane.

  1994cited by this paper
• Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond.

  1993cited by this paper
• PHARMACOLOGY Drug delivery: lymphing along?

  1993cited by this paper
• Drug delivery: lymphing along?

  1993cited by this paper
• [Possibility of lymphatic absorption of epidermal growth factor from intestine].

  1993cited by this paper
• Effect of Oily Vehicles on Absorption of Mepitiostane by the Lymphatic System in Rats

  1992cited by this paper
• Effect of Bile on Absorption of Mepitiostane by the Lymphatic System in Rats

  1992cited by this paper
• Improved oral bioavailability of propranolol in healthy human volunteers using a liver bypass drug delivery system containing oleic acid

  1992cited by this paper
• Intrinsic Lymphatic Partition Rate of Mepitiostane, Epitiostanol, and Oleic Acid Absorbed from Rat Intestine

  1991cited by this paper
• Bioavailability of a poorly water-soluble drug from tablet and solid dispersion in humans.

  1991cited by this paper
• An experimental animal model for studying the effects of a novel lymphatic drug delivery system for propranolol

  1991cited by this paper
• Drug Targeting Towards the Lymphatics

  1991cited by this paper
• Absorption and disposition of epithiosteroids in rats (2): Avoidance of first-pass metabolism of mepitiostane by lymphatic absorption.

  1991cited by this paper
• Absorption and disposition of epithiosteroids in rats (1): Route of administration and plasma levels of epitiostanol.

  1991cited by this paper
• Intestinal aspects of lipid absorption: in review.

  1989cited by this paper
• Intestinal Aspects of Lipid Absorption: In Review

  1989cited by this paper
• Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres.

  1989cited by this paper
• Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions.

  1988cited by this paper
• Lymphatic absorption of hypolipidemic compound, 1-O-[p-(myristyloxy)-alpha-methylcinnamoyl] glycerol (LK-903).

  1988cited by this paper
• Studies on intestinal lymphatic absorption of drugs. II. Glyceride prodrugs for improving lymphatic absorption of naproxen and nicotinic acid.

  1988cited by this paper
• In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles

  1988cited by this paper
• Partitioning of polar fatty acids into lymph and portal vein after intestinal absorption in the rat.

  1987cited by this paper
• Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules

  1986influential reference
• Formation and transport of chylomicrons by enterocytes to the lymphatics.

  1986cited by this paper
• Polychlorinated Biphenyl Uptake and Transport by Lymph and Plasma Components 1

  1985cited by this paper
• Factors regulating the exchange of nutrients and drugs between lymph and blood in the small intestine.

  1984cited by this paper
• The absorption of lipid and lipoprotein synthesis.

  1984cited by this paper
• Factors regulating the exchange of nutrients and drugs between lymph and blood in the small intestine.

  1984cited by this paper
• The effect of different oils on the absorption of probucol in the rat

  1984cited by this paper
• The role of the lymphatic transport in the enteral absorption of naftifine by the rat.

  1984cited by this paper
• Lipid digestion and absorption.

  1983cited by this paper
• Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats.

  1983cited by this paper
• Mechanisms of intestinal fat absorption.

  1981cited by this paper
• Activation of fast skeletal muscle: contributions of studies on skinned fibers.

  1981cited by this paper
• Portal venous transport of long-chain fatty acids absorbed from rat intestine.

  1980cited by this paper
• Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man

  1976cited by this paper
• The lymphocytic absorption of p,p'-DDT and some structurally-related compounds in the rat.

  1976cited by this paper
• The role of micellar solubilization in lipid absorption.

  1972cited by this paper
• The transport of exogenous cholesterol in the rabbit. I. Role of cholesterol ester of lymph chylomicra and lymph very low density lipoproteins in absorption.

  1972cited by this paper
• Intestinal absorption and lymphatic transport of d,1-3,4-3H2-a-tocopheryl nicotinate in the rat.

  1970cited by this paper
• The composition and structure of lymph chylomicrons in dog, rat, and man.

  1965cited by this paper
• Triglyceride biosynthesis in the intestinal mucosa.

  1965cited by this paper
• Physico-chemical state of lipids in intestinal content during their digestion and absorption.

  1962cited by this paper
• Direct measurement of cholesterol absorption via the thoracic duct in man.

  1960cited by this paper
• THE MECHANISM OF CHOLESTEROL ABSORPTION

  1959cited by this paper
• Effect of digestion on distribution of blood flow in the rat.

  1957cited by this paper
• Studies of intestinal digestion and absorption in the human.

  1957cited by this paper
• C14 cholesterol. I. Lymphatic transport of absorbed cholesterol-4-C14.

  1952cited by this paper
• Intestinal Lymphatic Transport of Absorbed Cholesterol.∗

  1951cited by this paper
• Techniques for the collection of lymph from the liver, small intestine, or thoracic duct of the rat.

  1948cited by this paper

• State-of-the-art drug delivery system to target the lymphatics

  2024cites this paper
• Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.

  2023cites this paper
• Engineering Nano‐ and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport

  2021cites this paper
• Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine

  2021cites this paper
• Lipid Nanocarriers: Promising Approach for Oral Drug Delivery System

  2020cites this paper
• Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement

  2020cites this paper
• Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties

  2020cites this paper
• A Comprehensive Framework for Physiologically‐Based Pharmacokinetic Modeling in Matlab

  2019cites this paper
• Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides.

  2017cites this paper
• Bioactive peptides in plant-derived foodstuffs.

  2016cites this paper
• Biodistribution, pharmacokinetics and toxicity of a Vasconcellea cundinamarcensis proteinase fraction with pharmacological activity

  2016cites this paper
• Improved intestinal lymphatic drug targeting via phospholipid complex-loaded nanolipospheres of rosuvastatin calcium

  2016cites this paper
• Bioavailability of aspirin in rats comparing the drug's uptake into gastrointestinal tissue and vascular and lymphatic systems: implications on aspirin's chemopreventive action.

  2016cites this paper
• Self-Emulsifying Drug Delivery Systems (SEDDS) in Pharmaceutical

  2015cites this paper
• Micro- and Nanoparticles: Protein and Peptide Oral Delivery

  2015cites this paper
• Recent advances in food biopeptides: production, biological functionalities and therapeutic applications.

  2015cites this paper
• Biologically Active Peptides from Foods

  2015cites this paper
• Polymeric Nano/Microparticles for Oral Delivery of Proteins and Peptides

  2015cites this paper
• Biomimetic reassembled chylomicrons as novel association model for the prediction of lymphatic transportation of highly lipophilic drugs via the oral route.

  2015cites this paper
• Self-Emulsifying Drug Delivery Systems (SEDDS) in Pharmaceutical Development

  2015cites this paper
• Handbook of Encapsulation and Controlled Release

  2015cites this paper
• Amphotericin B microparticles ‘AmbiShell’ from phospholipid and gelatin: Development and investigation by combined DLS and SANS resolves the core‐shell structure

  2014cites this paper
• An evolutionary perspective on intestinal lymphatic fat absorption, the industrialization of food, and allergy.

  2014cites this paper
• Novel S1P(1) receptor agonists--part 2: from bicyclo[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes.

  2014cites this paper
• Pentapeptides as minimal functional units in cell biology and immunology.

  2013cites this paper
• Strategies for the design of orally bioavailable antileishmanial treatments.

  2013cites this paper
• Delivery Systems for Lymphatic Targeting

  2013cites this paper
• IN VITRO IN VIVO METHODS AND PHARMACOKINETIC MODELS FOR SUBCUTANEOUSLY ADMINISTERED PEPTIDE DRUG PRODUCTS

  2012cites this paper
• Peptide therapeutics: it's all in the delivery.

  2012cites this paper
• Influence of a Fat‐Rich Meal on Bioavailability of Extended‐Release and Immediate‐Release Propiverine

  2012cites this paper
• Structure-activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis.

  2011cites this paper
• Quantifying exploratory low dose compounds in humans with AMS.

  2011cites this paper
• Enhanced oral cefotaxime sodium bioavailability after administration of cefotaxime-loaded Eudragit S100 nanoparticles and its influence on the lymphatic transport

  2010cites this paper
• ntioxidative peptides from food proteins : A review

  2010cites this paper
• The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride‐rich lipoproteins: in‐silico prediction of uptake by chylomicrons

  2009cites this paper
• Block Copolymer Micelles as Nanocontainers for Controlled Release of Proteins from Biocompatible Oil Phases

  2009cites this paper
• Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.

  2008cites this paper
• Assessing the Antifungal Activity of a New Oral Lipid-Based Amphotericin B Formulation Following Administration to Rats Infected with Aspergillus Fumigatus

  2007cites this paper
• Utilizing peptide structures as keys for unlocking challenging targets.

  2006cites this paper
• Peptide aptamers: recent developments for cancer therapy

  2005cites this paper
• Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.

  2005cites this paper
• Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.

  2005cites this paper
• The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen

  2005cites this paper
• Potential Mechanisms by Which Peceol® Increases the Gastrointestinal Absorption of Amphotericin B

  2004cites this paper
• A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: Cannulation of the mesenteric and thoracic lymph ducts within the rat.

  2004cites this paper
• Literature Watch

  2003cites this paper
• Literature Alerts

  2003cites this paper
• Effect of Lipid Excipients on In Vitro Pancreatic Lipase Activity

  2003cites this paper
• Effects of Lipid-Based Oral Formulations on Plasma and Tissue Amphotericin B Concentrations and Renal Toxicity in Male Rats

  2003cites this paper
• UNIVERSIDADE DE SÃO PAULO

  2001cites this paper